3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pancreatic Neoplasms
4
Ovarian Neoplasms
4
Neoplasm Metastasis
4
Colorectal Neoplasms
4
Sarcoma
3
Sarcoma, Ewing
2
Insulin-Like Growth Factor I, Resistance To
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoid Tumor
2
Breast Neoplasms
2
Small Cell Lung Carcinoma
1
Rhabdomyosarcoma, Embryonal
1
Rhabdomyosarcoma, Alveolar
1
Rhabdomyosarcoma
1
Recurrence
1
Rectal Neoplasms
1
Pleural Effusion, Malignant
1
Neuroendocrine Tumors
1
Neoplasms
1
Lymphoma
1
Lung Neoplasms
1
Jaundice
1
Gastrointestinal Neoplasms
1
Endocrine Gland Neoplasms
1
Colonic Neoplasms
1
Adenoma, Islet Cell
1
Adenocarcinoma
1
Interventions
Ifosfamide
6
X-Rays
5
Phantoms, Imaging
5
Magnetic Resonance Spectroscopy
5
Filgrastim
5
Etoposide
5
Doxorubicin
5
Cyclophosphamide
5
Vincristine
4
Temozolomide
4
Specimen Handling
4
Radiotherapy
4
Nuclear Medicine Department, Hospital
4
Melphalan
4
Thiotepa
3
Irinotecan
3
Biopsy
3
Bevacizumab
3
ulixertinib
2
trioctyl phosphine oxide
2
tipifarnib
2
temsirolimus
2
tazemetostat
2
selpercatinib
2
palbociclib
2
olaparib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
cixutumumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Neuroectodermal Tumors, Primitive, Peripheral
×
ganitumab
×
Clear all
No trials found.